A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR)
1 sources1 storiesFirst seen 7/16/2026Score32Mixed Progress
Single Source
Bigness
32
Coverage
13
Recency
95
Engagement
19
Velocity
0
Confidence
50
Clipability
42
Polarization
0
Claims
1
Contradictions
0
Breakthrough
50
Sentiment Mix
Positive0%
Neutral100%
Negative0%
Expert Signals
Politics - Google News US Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR).
Supported by 2 stories
Related Events
Poor air quality from wildfires sparking health concerns
Uncategorized • 7/17/2026
Second rare cancer strain emerges as Southern California cluster grows - New York Post
Uncategorized • 7/17/2026
Israel-Lebanon ceasefire extended by three weeks, Trump says - Reuters
Product Launch • 7/17/2026
White House says ICE traffic stops will continue after deadly shootings - NPR
Uncategorized • 7/17/2026
The Uplift: Desmond Bryant
Uncategorized • 7/17/2026
Timeline (1 stories)
Jul 17 02:51 AMFirst
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR)Politics - Google News US Headlines